Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection

COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid syndrome. We present a case in which antiphospholipid...

Descripción completa

Detalles Bibliográficos
Autores principales: Bitterman, Lauren, Solhjoo, Mahdis, Shah, Vivek, Kwon, Sue Min, Torralba, Karina, Kazbour, Hana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102817/
https://www.ncbi.nlm.nih.gov/pubmed/37052044
http://dx.doi.org/10.1177/23247096231165736
Descripción
Sumario:COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid syndrome. We present a case in which antiphospholipid antibodies were detected in the presence of significant thromboses. The patient was subsequently treated for suspected catastrophic antiphospholipid syndrome following COVID-19 infection.

Ejemplares similares